OPH offers both Pfizer & Moderna bivalent mRNA COVID-19 vaccines for anyone 6 months of age and older*.The Office of Public Health (OPH) is currently taking appointments for COVID-19 vaccinations: No changes were made to the recommendations for the use of monovalent Novavax and Janssen (Johnson & Johnson) COVID-19 vaccines.Due to a lack of data, FDA did not extend this authorization to children younger than age 5 who received Pfizer-BioNTech COVID-19 vaccination.Individuals who are immunocompromised who received a bivalent mRNA vaccine dose have the option to receive a second bivalent mRNA vaccine dose at least 2 months after their most recent dose, and subsequent doses at the discretion of their healthcare provider.Adults aged 65 years and older who have received a bivalent mRNA vaccine dose have the option to receive a second bivalent mRNA dose at least 4 months after their most recent dose.Children age 6 months through 5 years should receive a primary series of at least two doses (with at least one bivalent dose), but the total number of doses needed is determined by the formulation used and the number of previous doses.Previously unvaccinated people age 6 years and older, and those in that age group who have not received a bivalent mRNA COVID-19 vaccine, are considered fully vaccinated following a single bivalent dose.Monovalent mRNA vaccines are no longer authorized for use in the United States.The Bivalent mRNA COVID-19 vaccines are authorized for all recommended doses for people age 6 months and older. The CDC’s most recent statement on April 19, 2023, endorses the following changes to COVID-19 vaccine recommendations: Please call 61 to schedule an appointment. Eligibility for immunocompromised children under 5 depends on the vaccine previously received – please talk to your provider.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |